Inhibitory effect of c-Met mutants on the formation of branching tubules by a porcine aortic endothelial cell line

Cancer Science

Volumn 97, Issue 12, 2006, Pages 1343-1350

  Maemura, Marino ^a   Yoshimoto, Akira ^a   Tsukada, Yu Ichi ^a   Morishita, Yasuyuki ^b   Miyazawa, Keiji ^b   Tanaka, Toshiaki ^a   Kitamura, Naomi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN GEL; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUTANT PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; WORTMANNIN;

ANIMAL CELL; AORTA; ARTICLE; BRANCHING MORPHOGENESIS; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; PHENOTYPE; PLASMID; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AORTA; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEPATOCYTE GROWTH FACTOR; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; SWINE;

EID: 33750293432     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00335.x     Document Type: Article

References (41)

1. Miyazawa K, Tsubouchi H, Naka D et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-73.
2. Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3.
3. Rubin JS, Chan AM-L, Bottaro DP et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 415-19.
4. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature 1987; 327: 239-42.
5. Weidner KM, Arakaki N, Hartmann G et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001-5.
6. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-8.
7. Rosario M, Birchmeier W. How to make tubes: Signaling by the Met receptor tyrosine kinase. Trends Cell Biol 2003; 13: 328-35.
8. Bussolino F, Di Renzo MF, Ziche M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-41.
9. Grant DS, Kleinman HK, Goldberg ID et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937-41.
10. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. In: Goldberg ID, Rosen EM, eds. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-Met Receptor. Basel: Birkhauser-Verlag, 1993; 225-49.
11. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-25.
12. Schmidt C, Bladt F, Goedecke S et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699-702.
13. Uehara Y, Minowa O, Mori C et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373: 702-5.
14. Bottaro DP, Rubin JS, Faletto DL et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-4.
15. Naldini L, Weidner KM, Vigna E et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991; 10: 2867-78.
16. Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 1993; 121: 145-54.
17. Komada M, Kitamura N. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor. Oncogene 1993; 8: 2381-90.
18. Komada M, Kitamura N. Regulatory role of major tyrosine auto-phosphorylation site of kinase domain of c-Met receptor (scatter factor/hepatocyte growth factor receptor). J Biol Chem 1994; 269: 16131-6.
19. Longati P, Bardelli A, Ponzetto C, Naldini L, Comoglio PM. Tyrosines 1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 1994; 9: 49-57.
20. Ponzetto C, Bardeli A, Zhen Z et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/ scatter factor receptor family. Cell 1994; 77: 261-71.
21. Zhu H, Naujokas MA, Fixman ED, Torossian K, Park M. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis. J Biol Chem 1994; 269: 29943-8.
22. Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J, Bichmeier W. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 1996; 384: 173-6.
23. Danilkovitch-Miagkova A, Zbar B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 2002; 109: 863-7.
24. Jeffers M, Schmidt L, Nakaigawa L et al. Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 1997; 94: 11 445-50.
25. Jeffers M, Fiscella M, Webb CP, Anver M, Koochekpour S, Vande Woude GF. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci USA 1998; 95: 14417 -22.
26. Giordano S, Mafee A, Williams TA et al. Different point mutations in the met oncogene elicit distinct biological properties. FASEB J 2000; 14: 399-406.
27. Strain AJ, Ismail T, Tsubouchi H et al. Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest 1991; 87: 1853-7.
28. Miyazono K, Okabe T, Urabe A, Yamanaka M, Takaku F. A platelet factor that stimulates the proliferation of vascular endothelial cells. Biochem Biophys Res Commun 1985; 126: 83-8.
29. Nakamura T, Kanda S, Yamamoto K et al. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Oncogene 2001; 20: 7610-23.
30. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 2001; 159: 993-1008.
31. Rosen EM, Grant D, Kleinman H et al. Scatter factor stimulates migration of vascular endothelium and capillary-like tube formation. In: Goldberg ID, ed. Cell Motility Factors. Basel: Birkhauser-Verlag, 1991; 77-88.
32. Derman MP, Cunha MJ, Barros EJG, Nigam SK, Cantley LG. HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase. Am J Physiol 1995; 268: F1211-17.
33. Khwaja A, Lehmann K, Marte BM, Downward J. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J Biol Chem 1998; 273: 18793-801.
34. Terauchi R, Kitamura N. Requirement of regulated activation of Ras for response of MDCK cells to hepatocyte growth factor/scatter factor. Exp Cell Res 2000; 256: 411-22.
35. Royal I, Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem 1995; 270: 27780-7.
36. Potempa S, Ridley AJ. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 1998; 9: 2185-200.
37. Maeshima A, Zhang Y-Q, Furukawa M, Naruse T, Kojima I. Hepatocyte growth factor induces branching tubulogenesis in MDCK cells by modulating the activin-follistatin system. Kidney Int 2000; 58: 1511-22.
38. Miller M, Ginalski K, Lesyng B, Nakaigawa N, Schmidt L, Zbar B. Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies. Proteins 2001; 44: 32-43.
39. Maroun CR, Naujokas MA, Holgado-Madruga M, Wong AJ, Park M. The tyrosine phosphatase SHP-2 required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase. Mol Cell Biol 2000; 20: 8513-25.
40. Ma PC, Kijima T, Maulik G et al. c-Met mutational analysis in small cell lung cancer: Novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 2003; 63: 6272-81.
41. Graveel C, Su Y, Koeman J et al. Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele. Proc Natl Acad Sci USA 2004; 101: 17198-203.